Invention Grant
- Patent Title: Imidazotriaines and imidazopyrimidines as kinase inhibitors
-
Application No.: US16909686Application Date: 2020-06-23
-
Publication No.: US11261191B2Publication Date: 2022-03-01
- Inventor: Jincong Zhuo , Meizhong Xu , Chunhong He , Colin Zhang , Ding-Quan Qian , David M. Burns , Yun-Long Li , Brian Metcalf , Wenqing Yao
- Applicant: Incyte Corporation , Incyte Holdings Corporation
- Applicant Address: US DE Wilmington; US DE Wilmington
- Assignee: Incyte Corporation,Incyte Holdings Corporation
- Current Assignee: Incyte Corporation,Incyte Holdings Corporation
- Current Assignee Address: US DE Wilmington; US DE Wilmington
- Agency: Lathrop GPM LLP
- Agent Brian C. Trinque
- Main IPC: C07D487/04
- IPC: C07D487/04 ; C07D403/06 ; A61P35/00 ; A61K31/53 ; A61K31/4709
Abstract:
The present invention is directed to imidazo[1,2-b][1,2,4]triazines and imidazo[1,2-a]pyrimidines, and pharmaceutical compositions thereof, which are inhibitors of kinases such as c-Met and are useful in the treatment of cancer and other diseases related to the dysregulation of kinase pathways.
Public/Granted literature
- US20200317680A1 Imidazotriaines and Imidazopyrimidines as Kinase Inhibitors Public/Granted day:2020-10-08
Information query
